Edesa Biotech Inc. (EDSA)
NASDAQ · Healthcare
Edesa Biotech Inc. Shareholder Equity 2012–2021
Edesa Biotech Inc. annual shareholder equity history from 2013 to 2021. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Edesa Biotech Inc. shareholder equity as of September 30, 2021: 13.1M, a 96.92% increase year-over-year.
- Edesa Biotech Inc. shareholder equity for 2021 were 13.1M, a 96.92% increase from 2020.
- Edesa Biotech Inc. shareholder equity for 2020 were 6.6M, a 106.29% increase from 2018.
- Edesa Biotech Inc. shareholder equity for 2018 were 3.2M, a 56.56% decrease from 2017.
- Edesa Biotech Inc. shareholder equity for 2017 were 7.4M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Edesa Biotech Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2021 | $13 |
| 2020 | $7 |
| 2018 | $3 |
| 2017 | $7 |
| 2016 | $12 |
| 2015 | $8 |
| 2014 | $8 |
| 2013 | $-2 |
Edesa Biotech Inc. Shareholder Equity — FAQ
Edesa Biotech Inc. (EDSA) shareholder equity over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see EDSA's shareholder equity history?
The chart and table above show Edesa Biotech Inc.'s shareholder equity by year and by quarter, including the growth rate.